CN202568363U - Blood occlusion saccule for sclerotherapy for esophageal varices - Google Patents
Blood occlusion saccule for sclerotherapy for esophageal varices Download PDFInfo
- Publication number
- CN202568363U CN202568363U CN 201220201709 CN201220201709U CN202568363U CN 202568363 U CN202568363 U CN 202568363U CN 201220201709 CN201220201709 CN 201220201709 CN 201220201709 U CN201220201709 U CN 201220201709U CN 202568363 U CN202568363 U CN 202568363U
- Authority
- CN
- China
- Prior art keywords
- saccule
- sacculus
- gas
- aeration
- charging connection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The utility model discloses a blood occlusion saccule for sclerotherapy for esophageal varices. The blood occlusion saccule comprises a round tube-shaped saccule inner sleeve, an annular tubular saccule made of medical emulsion materials is sheathed by surrounding the outer wall of the saccule inner sleeve, an aeration pipeline is inserted between the outer wall of the saccule inner sleeve and the tubular saccule, one end of the outer wall, wherein the aeration pipeline is arranged, is connected with the tubular saccule, a plurality of aeration holes are formed in the connection position of the aeration pipeline and the tubular saccule, the aeration pipeline is communicated with the tubular saccule by the aeration holes, one end of the tail of the aeration pipeline, not connected with the tubular saccule, is connected with an aeration joint which is communicated with the aeration pipeline, and the outer wall wherein the aeration joint is arranged is connected with an aeration joint plug by a connecting strip made of soft silica gel. The blood occlusion saccule solves the problem that the injection amount of esophageal varices hardening agent is redundant, and reduces the complications such as local continuous bleeding, ectopia blood vessels and viscera embolism under the premise of achieving the satisfied treatment effect.
Description
Technical field
This utility model belongs to technical field of medical instruments, relates to the bloodstream blocking sacculus that a kind of sclerotherapy for esophageal varices is used.
Background technology
At present, the digestive endoscopy doctor is everlasting and finds to have following three problems in the clinical practice:
1) in esophageal varicosis sclerosing agent (like 1% aethoxysklerol injection etc.) injection for curing; If when extracting entry needle behind the injection of sclerosing agent; Because thrombosis speed is slower, continuous bleeding possibly take place in the injection pin hole, and it is dangerous to have influenced treatment operating time and severe bleeding;
2) dosage of thrombosis speed, hardening effect and sclerosing agent has dose-effect positive tropism relation in the sclerosing agent treatment medium-sized vein, therefore in treatment, usually need increase the sclerosing agent using dosage, thereby increase the risk of dystopy thromboembolism;
3) ordinary circumstance next time sclerotherapy be difficult to reach satisfactory effect, need treatment repeatedly could eliminate varicosis.
After its main cause is injection of sclerosing agent in vein; Medicine runs off rapidly with intravenous blood flow; Injection site intravenous sclerosing agent concentration is also decreased; Thereby postponed the thrombotic time of local intravenous, increased the risk of injection site continuous bleeding, or therefore caused the patient that dead danger takes place.Simultaneously, because the intravenous VPV is very fast, when sclerosing agent loss back is as if the injection site continuous bleeding in the blood flow, append the dosage that injects sclerosing agent after needing.Research at present shows that injection of sclerosing agent too much possibly cause outer ectopic vessel of esophagus and internal organs thromboembolism danger, and the most common is pulmonary embolism.Thereby, stress that clinically once injecting human body sclerosing agent accumulated dose (like 1% aethoxysklerol injection) will control within the specific limits, in order to avoid cause the generation of severe complications such as ectopic vessel and internal organs thromboembolism.
Therefore, how in sclerotherapy, should guarantee the sclerotherapy effect, reduce differential hardening agent ID again, its key is to improve the concentration of local intravenous sclerosing agent, promotes the intravenous thrombosis to form rapidly.Thereby after avoiding extracting entry needle continued hemorrhage takes place, and reduce the sclerosing agent using dosage as far as possible, the probability that prevention ectopic vessel and internal organs thromboembolism take place.
Summary of the invention
The purpose of this utility model provides the bloodstream blocking sacculus that a kind of sclerotherapy for esophageal varices is used; Solved in the treatment of esophageal varicosis injection of sclerosing agent; Use a small amount of sclerosing agent; Can improve the differential hardening agent concentration, quicken local vein blood vessel hardening effect, avoid sclerosing agent excessive and cause the problem of complication such as ectopic vessel, internal organs thromboembolism.
The technical scheme that this utility model adopted is; The bloodstream blocking sacculus that a kind of sclerotherapy for esophageal varices is used; Comprise cover in the piped sacculus of circle, be socketed with the tubulose sacculus that annular medical latex material is processed, be inserted with an end of aerating pipe between sacculus outer wall of inside race and the tubulose sacculus inwall around the sacculus outer wall of inside race; Aerating pipe one end outer wall is connected with the tubulose sacculus; Aerating pipe and tubulose sacculus junction have some air-filled pores, and aerating pipe is communicated with through air-filled pore with the tubulose sacculus, and aerating pipe is not connected an end with the tubulose sacculus and is connected with gas-charging connection; Gas-charging connection is communicated with aerating pipe, and the connection strap that the gas-charging connection outer wall is processed through soft silica gel is connected with the gas-charging connection plug.
The characteristics of this utility model also are,
Wherein gas-charging connection is hollow truncated cone-shaped, and it is round table-like that gas-charging connection plug and gas-charging connection cavity shape adapt.
The beneficial effect of this utility model is, thus through the tubulose sacculus expand blocking-up or slow to down and on the esophageal veins blood flow that flowing, reduced esophageal varicosis sclerosing agent implantation dosage under the scope; Increase sclerosing agent concentration gathering in the local vascular; Promote the speed that local thrombus forms, make under the scope sclerotherapy for esophageal varices safer, have higher success rate; Curative effect is more satisfied, and complication still less.
Description of drawings
Fig. 1 is the bloodstream blocking balloon configuration sketch map that a kind of sclerotherapy for esophageal varices of this utility model is used.
Among the figure, 1. tubulose sacculus; 2. overlap in the sacculus; 3. aerating pipe; 4. air-filled pore; 5. inflatable chamber; 6. gas-charging connection; 7. connection strap; 8. gas-charging connection plug.
The specific embodiment
Below in conjunction with the accompanying drawing and the specific embodiment this utility model is elaborated.
The bloodstream blocking sacculus that this utility model provides a kind of sclerotherapy for esophageal varices to use, as shown in Figure 1, comprise cover 2 in the piped sacculus of circle; Cover 2 outer walls are socketed with the tubulose sacculus 1 that annular medical latex material is processed in sacculus, are inserted with an end of aerating pipe 3 in the sacculus between cover 2 outer walls and tubulose sacculus 1 inwall, and aerating pipe 3 one end outer walls are connected with tubulose sacculus 1; Aerating pipe 3 has some air-filled pores 4 with tubulose sacculus 1 junction; Aerating pipe 3 is communicated with through air-filled pore 4 with tubulose sacculus 1, and when air-filled pore 4 was in inflated condition, tubulose sacculus 1 can the annular expansion take place and produce inflatable chamber 5 because of inflation; Inflatable chamber 5 distributes ringwise; Aerating pipe 3 is not connected an end with tubulose sacculus 1 and is connected with gas-charging connection 6, and gas-charging connection 6 is hollow truncated cone-shaped, and gas-charging connection 6 is communicated with aerating pipe 3; The connection strap 7 that gas-charging connection 6 outer walls are processed through soft silica gel is connected with gas-charging connection plug 8, gas-charging connection plug 8 for gas-charging connection 6 cavity shapes adapt round table-like.
Wherein aerating pipe 3 middle interconnecting pieces branch and gas-charging connection 6 are free state; Earlier cover in the sacculus of tubulose sacculus 12 is inserted in the certain position of shank (apart from camera lens 5-10cm) from the scope front end before the therapeutic endoscopy; Again with aerating pipe 3 middle interconnecting piece segmentations (at interval 10cm) with medical adhesive tape to time and on be fixed on the scope; Until being fixed in place, endoscope movable detecting hole below, at last gas-charging connection 6 is remained in the endoscope movable detecting hole below with free state.
The function of tubulose sacculus 1 is: during its inflation annular taking place expands, but the blood flow in the esophageal veins of the instantaneity blocking-up or the varicose of slowing down.
The function of gas-charging connection 6 and aerating pipe 3 is: provide in tubulose sacculus 1, to inflate and make it to take place annular and expand.
The function of connection strap 7 and gas-charging connection plug 8 is: in advance through gas-charging connection 6 and aerating pipe 3 in tubulose sacculus 1 inflation behind blocking blood flow; Prevention tubulose sacculus gas leaks outside, and keeps tubulose sacculus 1 inner pressure constant and volume to reach blood flow effect in the blocking-up esophageal veins.
The operation principle of the bloodstream blocking sacculus that this utility model provided is: 1, according to pathology thrombosis principle: promptly VPV slows down, local eddy currents, angiostenosis and obturation all help thrombosis; 2, sclerosants treatment principle: promptly slower, the sclerosing agent concentration of VPV is high more in the blood vessel helps local thrombus shape more.
This utility model operation principle is main to be designed according to above-mentioned medicine principle, and it selects the patient of the esophageal varicosis of diagnosis under the scope is treatment target.Earlier tubulose sacculus 1 and aerating pipe 3 are installed on the scope before the treatment.After inserting scope and choosing puncture target vein, an amount of from gas-charging connection 6 injecting gas, tubulose sacculus 1 expand thereby can block or slow to down and on the esophageal veins blood flow that flowing; This moment puncture vein and inject sclerosing agent after, local intravenous sclerosing agent concentration is assembled rapidly, the sclerosing agent and the blood of high concentration are had an effect; Make intravenous blood and solidify rapidly and form thrombosis; After withdrawing from the injection nook closing member, because the pin hole continued hemorrhage does not generally take place local intravenous thrombosis; Secondly, because tubulose sacculus 1 contention effect makes intravenous bloodstream blocking or slows down, quickened sclerosing agent and local blood response time, reduced sclerosing agent and run off, thereby reduced the esophagus probability of blood vessel embolism outward with quick mobile blood flow; At last, owing to reduced the accumulated dose that sclerosing agent uses, use the excessive probability that causes outer ectopic vessel of esophagus and internal organs thromboembolisms thereby reduced because of sclerosing agent.
The method for using step of this utility model bloodstream blocking sacculus is:
1) selecting the patient of the esophageal varicosis of diagnosis under the scope is treatment target;
2) earlier cover in the sacculus of tubulose sacculus 12 is inserted in the certain position of shank (apart from camera lens 5-10cm) from the scope front end before the treatment; At the scope front end hyaline cap is installed; Again with aerating pipe 3 middle interconnecting piece segmentations (at interval 10cm) with medical adhesive tape to time and on be fixed on the scope; Until being fixed in place, endoscope movable detecting hole below; At last the gas-charging connection part is remained in the endoscope movable detecting hole below with free state, connect gas-charging connection 6 and attract gas in the tubulose sacculus 1, keep it to be in negative pressure state with injector for medical purpose;
3) after the patient gets left lateral position, oral area on an empty stomach and worn bite-block and induced anesthesia, insert scope 1-2cm place on the cardia pectinate line, choose puncture injection target vein, fixedly scope;
4) assistant is an amount of from gas-charging connection 6 injecting gas with injector for medical purpose, when the most of blocking-up of local venous blood flow;
5) from target spot puncture vein and inject sclerosing agent 2-3ml fast, withdraw from nook closing member, continue the compressing injection orifice about 10 seconds with entry needle epitheca or hyaline cap outer rim, finds no active hemorrhage after, move to the next one target spot that punctures.Repeat said process, until accomplishing all treatments.
6) after the no active hemorrhage of inspection, withdraw from scope, stopped treatment.
The advantage of this utility model bloodstream blocking sacculus is:
1) improves efficient and the safety that the esophageal varicosis injection of sclerosing agent is treated under the scope.Through intravenous blood flow under the mucous membrane of esophagus of inflating balloon blocking-up near-end varicose, reduce the dosage of every some injection of sclerosing agent, the aggregate concentration that it increases local intravenous sclerosing agent has improved local vascular thrombosis speed.Reduce sclerosing agent use accumulated dose thereby reach, avoid the generation of complication such as local hemorrhage, the outer blood vessel of esophagus and internal organs dystopy thromboembolism as far as possible.
2) simple in structure, easy to use, safe and reliable, economical and practical.This utility model is the novel specific auxiliary facilities that provides to injection of sclerosing agent treatment under the esophageal varicosis scope, adopts avirulence medical latex and plastic material to process tubulose sacculus and gas injection system.Its structure is very simple, and production and use cost are cheap, and material therefor is to the human non-toxic side effect.
Claims (2)
1. bloodstream blocking sacculus that sclerotherapy for esophageal varices is used; It is characterized in that; Comprise cover (2) in the piped sacculus of circle; Cover (2) outer wall is socketed with the tubulose sacculus (1) that annular medical latex material is processed in sacculus; Be inserted with an end of aerating pipe (3) in the sacculus between cover (2) outer wall and tubulose sacculus (1) inwall, aerating pipe (3) one end outer walls are connected with tubulose sacculus (1), and aerating pipe (3) has some air-filled pores (4) with tubulose sacculus (1) junction; Aerating pipe (3) is communicated with through air-filled pore (4) with tubulose sacculus (1); Aerating pipe (3) is not connected an end with tubulose sacculus (1) and is connected with gas-charging connection (6), and gas-charging connection (6) is communicated with aerating pipe (3), and the connection strap (7) that gas-charging connection (6) outer wall is processed through soft silica gel is connected with gas-charging connection plug (8).
2. bloodstream blocking sacculus according to claim 1 is characterized in that, said gas-charging connection (6) is hollow truncated cone-shaped, gas-charging connection plug (8) for gas-charging connection (6) cavity shape adapt round table-like.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220201709 CN202568363U (en) | 2012-05-04 | 2012-05-04 | Blood occlusion saccule for sclerotherapy for esophageal varices |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220201709 CN202568363U (en) | 2012-05-04 | 2012-05-04 | Blood occlusion saccule for sclerotherapy for esophageal varices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202568363U true CN202568363U (en) | 2012-12-05 |
Family
ID=47237826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201220201709 Expired - Fee Related CN202568363U (en) | 2012-05-04 | 2012-05-04 | Blood occlusion saccule for sclerotherapy for esophageal varices |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202568363U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670269A (en) * | 2012-05-04 | 2012-09-19 | 中国人民解放军第四军医大学 | Blood flow blocking balloon for esophageal varices hardening treatment under endoscope |
| CN104434296A (en) * | 2014-12-10 | 2015-03-25 | 江苏仁鸿医疗科技有限公司 | In-vivo lithotripter positioning device |
-
2012
- 2012-05-04 CN CN 201220201709 patent/CN202568363U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670269A (en) * | 2012-05-04 | 2012-09-19 | 中国人民解放军第四军医大学 | Blood flow blocking balloon for esophageal varices hardening treatment under endoscope |
| CN104434296A (en) * | 2014-12-10 | 2015-03-25 | 江苏仁鸿医疗科技有限公司 | In-vivo lithotripter positioning device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203852722U (en) | Aspiration and injection catheter apparatus with flow-limiting bladders | |
| CN103349564B (en) | Novel uterine cavity expander | |
| CN107929920A (en) | Can the double sacculus of filling type aorta clamping | |
| CN203089263U (en) | Hemostasis balloon for upper gastrointestinal hemorrhage | |
| CN202568363U (en) | Blood occlusion saccule for sclerotherapy for esophageal varices | |
| CN100484463C (en) | Gastroscope casing | |
| CN102670269A (en) | Blood flow blocking balloon for esophageal varices hardening treatment under endoscope | |
| CN209405464U (en) | A kind of internal flow controllable ischemia-reperfusion sacculus | |
| CN102657554A (en) | Endoscopic outer sleeve airbag with double hoses | |
| CN202589485U (en) | Endoscope jacket air bag with dual tubes | |
| CN211024713U (en) | Intracranial drug eluting balloon catheter | |
| CN205458882U (en) | Sacculus is blocked to buffering formula | |
| CN100448411C (en) | Blood vessel blocking drainage tube with thin wall sandwiched balloon | |
| CN106492325A (en) | A kind of drainage tube | |
| CN201048932Y (en) | Gastroscope external casing | |
| CN201008566Y (en) | Sandwich layer aerostats vas blocking-up drainage tubes | |
| CN209203498U (en) | A kind of stagewise tumour incision knife applied to Notes technology | |
| CN204219590U (en) | Air bag pressurized cavitary drug feeder | |
| CN209951322U (en) | Hemostatic sleeve for endoscope | |
| CN208660114U (en) | It can the double sacculus of filling type aorta clamping | |
| CN102335464B (en) | Injection and suction pump for removing thrombus | |
| CN105852918A (en) | Injection and expansion integrated device | |
| CN109381230A (en) | Abdominal hernia puncture outfit | |
| CN206652073U (en) | A kind of drainage tube | |
| CN207024037U (en) | A kind of Novel anti-drop fetus videoendoscopic surgery soft plastic puncture sheath |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121205 Termination date: 20140504 |